Codexis

Codexis Shares Outstanding

The The number of shares of Codexis (CDXS) as of Oct 15, 2026 is 90.32 M. In the previous year, The number of shares was 90.32 M — a change of 0.00% (lower).

Shares Outstanding

90.32 M

YoY

0.00%

Last updated:

In 2025, Codexis had 90.32 M outstanding stocks, a 0.00% change from the 90.32 M stocks in the previous year.

The Codexis Shares Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shares Outstanding
Date
Shares Outstanding
Jan 1, 2023
90.32 M USD
Jan 1, 2024
90.32 M USD
Jan 1, 2025
90.32 M USD
Jan 1, 2026 (e)
90.91 USD
Jan 1, 2027 (e)
90.91 USD
Jan 1, 2028 (e)
90.91 USD
Jan 1, 2029 (e)
90.91 USD
Jan 1, 2030 (e)
90.91 USD
The Codexis Shares Outstanding history
YEARShares OutstandingYoY
est90.910.00%
est90.910.00%
est90.910.00%
est90.910.00%
est90.91-100.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M0.00%
90.32 M+235.64 M%
38.33+1.99%
37.58+4.23%
36.06+2.68%
35.12+1,238.26%
2.62+1.16%
2.59-4.42%
2.71-97.02%
91.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Codexis Number of shares

Codexis shares outstanding

The number of shares of Codexis was 90.91 M in 2025. This indicates how many shares Codexis is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2023
69.50 M Stocks
Jan 1, 2024
81.30 M Stocks
Jan 1, 2025
90.91 M Stocks
Jan 1, 2026 (e)
90.91 M Stocks
Jan 1, 2027 (e)
90.91 M Stocks
Jan 1, 2028 (e)
90.91 M Stocks
Jan 1, 2029 (e)
90.91 M Stocks
Jan 1, 2030 (e)
90.91 M Stocks

Codexis Stock analysis

What does Codexis do? Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis is one of the most popular companies on Eulerpool.

Shares Outstanding Details

Evaluating Codexis's Shares Outstanding

Codexis's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Codexis’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Codexis’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Codexis’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Codexis stock

The number of shares of Codexis is 90.32 M in 2025.

The number of shares of Codexis changed from 90.32 M to 90.32 M, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The number of shares Codexis since 2006 – with annual values, charts, and detailed analysis.

The number of shares indicates the total number of a company's shares. This includes not only the shares available on the market, but also the shares held by shareholders and the shares retained by the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Codexis

All Key Metrics — Codexis